Author ORCID Identifier
Document Type
Article
Publication Date
9-29-2016
Publication Title
Vascular Medicine
Volume
21
Issue
6
First Page
489
Last Page
496
Abstract
Obesity is associated with the development of vascular insulin resistance; however, pathophysiological mechanisms are poorly understood. We sought to investigate the role of WNT5A-JNK in the regulation of insulin-mediated vasodilator responses in human adipose tissue arterioles prone to endothelial dysfunction. In 43 severely obese (BMI 44±11 kg/m2) and five metabolically normal non-obese (BMI 26±2 kg/m2) subjects, we isolated arterioles from subcutaneous and visceral fat during planned surgeries. Using videomicroscopy, we examined insulin-mediated, endothelium-dependent vasodilator responses and characterized adipose tissue gene and protein expression using real-time polymerase chain reaction and Western blot analyses. Immunofluorescence was used to quantify endothelial nitric oxide synthase (eNOS) phosphorylation. Insulin-mediated vasodilation was markedly impaired in visceral compared to subcutaneous vessels from obese subjects (pWNT5A and its non-canonical receptors, which correlated negatively with insulin signaling. Pharmacological JNK antagonism with SP600125 markedly improved insulin-mediated vasodilation by sixfold (pp
Recommended Citation
Farb MG, Karki S, Park SY, Saggese SM, Carmine B, Hess DT, Apovian C, Fetterman JL. Brenton- Romero R, Hamburg N, Fuster JJ, Walsh K, Gokce N. Wnt5a-JNK regulation of vascular insulin resistance in human obesity Vascular Medicine 16-2259 (IF: 1.438) https://doi.org/10.1177/1358863X16666693
Comments
This is an Accepted Manuscript of an article published by Sage in [JOURNAL TITLE] on [date of publication], available online: [Article DOI]
Reuse restricted to noncommercial and no derivative uses.